We are live on ! Find out more
EARNEST Partners

EARNEST Partners Portfolio holdings

AUM $27.7B Turnover 6.77%
1-Year Est. Return 52.44%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+52.44%
3 Year Est. Return
+92.17%
5 Year Est. Return
+120.28%
10 Year Est. Return
+519.8%
AUM
$10B
AUM Growth
+$518M
Cap. Flow
-$105M
Cap. Flow %
-1.05%
Top 10 Hldgs %
18.87%
Holding
233
New
8
Increased
78
Reduced
133
Closed
4
Avg Time Held
3.1 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
2.4 years

Sector Composition

Rank Sector Weight
1 Financials 23.16%
2 Industrials 19.65%
3 Technology 15.19%
4 Healthcare 13.48%
5 Consumer Discretionary 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DOV icon
126
Dover
DOV
$26.1B
$21.7M 0.22%
293,312
-7,070
-2% -$491K
2014 Q3
12 quarters
DIS icon
127
Walt Disney
DIS
$191B
$20.8M 0.21%
211,111
-12,999
-6% -$1.34M
2013 Q4
15 quarters
GS icon
128
Goldman Sachs
GS
$260B
$20.8M 0.21%
87,726
-5,745
-6% -$1.3M
2013 Q4
15 quarters
STFC
129
DELISTED
State Auto Financial Corp
STFC
$20.5M 0.2%
780,544
+18,219
+2% +$453K
2013 Q4
15 quarters
JPM icon
130
JPMorgan Chase
JPM
$891B
$20.2M 0.2%
211,468
-14,079
-6% -$1.3M
2013 Q4
15 quarters
ECHO icon
131
EchoStar
ECHO
$25.3B
$20.1M 0.2%
434,257
-12,126
-3% -$578K
2013 Q4
15 quarters
UNP icon
132
Union Pacific
UNP
$172B
$20M 0.2%
172,309
-10,358
-6% -$1.11M
2013 Q4
15 quarters
COR icon
133
Cencora
COR
$65.2B
$19M 0.19%
229,718
-6,128
-3% -$520K
2013 Q4
15 quarters
XEC
134
DELISTED
CIMAREX ENERGY CO
XEC
$18.3M 0.18%
160,638
-8,211
-5% -$819K
2016 Q1
6 quarters
ARRS
135
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$18.1M 0.18%
634,938
-834
-0.1% -$23.1K
2016 Q3
4 quarters
AVT icon
136
Avnet
AVT
$7.64B
$17.9M 0.18%
+454,543
New +$17.4M
2017 Q3
0 quarters
ADP icon
137
Automatic Data Processing
ADP
$113B
$16.1M 0.16%
147,173
-9,985
-6% -$1.07M
2013 Q4
15 quarters
ON icon
138
ON Semiconductor
ON
$28.7B
$15.6M 0.16%
844,317
-9,088
-1% -$146K
2014 Q4
11 quarters
KEYS icon
139
Keysight
KEYS
$58.2B
$15.5M 0.15%
371,293
-12,708
-3% -$520K
2014 Q4
11 quarters
SON icon
140
Sonoco
SON
$4.91B
$15M 0.15%
298,083
-3,163
-1% -$156K
2013 Q4
15 quarters
FDS icon
141
Factset
FDS
$10.7B
$14.7M 0.15%
81,754
-2,456
-3% -$401K
2014 Q4
11 quarters
HTLF icon
142
DELISTED
Heartland Financial USA, Inc.
HTLF
$13.4M 0.13%
272,154
+23,561
+9% +$1.08M
2017 Q2
1 quarter
BDX icon
143
Becton Dickinson
BDX
$52.8B
$13.2M 0.13%
68,946
-2,118
-3% -$411K
2013 Q4
15 quarters
RCL icon
144
Royal Caribbean
RCL
$74.9B
$13.1M 0.13%
110,315
-10,338
-9% -$1.21M
2015 Q2
9 quarters
APA icon
145
APA Corp
APA
$16.5B
$11.2M 0.11%
244,620
-14,106
-5% -$622K
2013 Q4
15 quarters
AFL icon
146
Aflac
AFL
$59.2B
$11.2M 0.11%
274,836
-18,534
-6% -$746K
2013 Q4
15 quarters
KMB icon
147
Kimberly-Clark
KMB
$34.6B
$11.1M 0.11%
94,480
-6,335
-6% -$774K
2013 Q4
15 quarters
BIG icon
148
DELISTED
Big Lots, Inc.
BIG
$10.6M 0.11%
197,959
-928
-0.5% -$45.7K
2015 Q3
8 quarters
PBR icon
149
Petrobras
PBR
$163B
$10.5M 0.1%
1,042,587
-24,081
-2% -$219K
2013 Q4
15 quarters
SO icon
150
Southern Company
SO
$103B
$10.2M 0.1%
206,959
-13,245
-6% -$642K
2013 Q4
15 quarters

Similar funds

EARNEST Partners's Q3 2017 Portfolio in Review

As of Q3 2017, EARNEST Partners held 233 positions worth $10B, up 5.4% from $9.52B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

EARNEST Partners's Q3 2017 filing shows 8 new, 78 increased, 133 reduced and 4 closed positions. Its largest new stake was Darling Ingredients: 3,984,504 shares worth $69.8M. The largest sale was Teva Pharmaceutical Industries Limited, an estimated $99.4M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • EARNEST Partners's largest Q3 2017 buy was Darling Ingredients: 3,984,504 shares worth $69.8M.
  • EARNEST Partners added most to Core Laboratories in Q3 2017, an estimated $11.2M increase.
  • EARNEST Partners's biggest Q3 2017 reduction was TSMC, cutting an estimated $29.1M.
  • EARNEST Partners fully exited Teva Pharmaceutical Industries Limited in Q3 2017, selling an estimated $99.4M.
  • EARNEST Partners's ten largest holdings make up 19% of its $10B portfolio in Q3 2017.
  • EARNEST Partners opened 8 new positions and closed 4 in Q3 2017.
  • EARNEST Partners's portfolio value rose 5.4% quarter-over-quarter to $10B.

Based on EARNEST Partners's 13F filing for Q3 2017, filed 14 Nov 2017.